The NLRC4 inflammasome drives myelodysplastic syndrome by linking epigenetic reprogramming and innate immune signaling
Blood Advances
· Elsevier
Аннотация
Publication date: 10 November 2026 Source: Blood Advances, Volume 10, Issue 21 Author(s): Chuan Chen, Fan Liu, Tasleem Arif, Na Man, Francesco Tamiro, Daniel Bilbao, Concepcion Martinez Caja, Krystal Hossack, Narges Rostami, Gloria Mas, Stephanie Duffort, Hidehiro Itonaga, Julio Poveda, Jennifer Chapman, Stephen D. Nimer
Читать у издателя →
Цитировать
Получайте новые статьи по теме «Гематология»
Подписка, поиск по ключевым словам и избранное — в Telegram-боте Articlium.
Открыть в Telegram
Цитирование
✕
ГОСТ
APA
MLA
BibTeX
The NLRC4 inflammasome drives myelodysplastic syndrome by linking epigenetic reprogramming and innate immune signaling. // Blood Advances. – URL: https://www.sciencedirect.com/science/article/pii/S2473952926005537?dgcid=rss_sd_all
The NLRC4 inflammasome drives myelodysplastic syndrome by linking epigenetic reprogramming and innate immune signaling. Blood Advances. https://www.sciencedirect.com/science/article/pii/S2473952926005537?dgcid=rss_sd_all
“The NLRC4 inflammasome drives myelodysplastic syndrome by linking epigenetic reprogramming and innate immune signaling.” Blood Advances.
@article{article88633,
title = {The NLRC4 inflammasome drives myelodysplastic syndrome by linking epigenetic reprogramming and innate immune signaling},
journal = {Blood Advances},
url = {https://www.sciencedirect.com/science/article/pii/S2473952926005537?dgcid=rss_sd_all}
}